Carbonic anhydrase inhibitors. Phenols incorporating 2- or 3-pyridyl-ethenylcarbonyl and tertiary amine moieties strongly inhibit Saccharomyces cerevisiae β-carbonic anhydrase

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 29, Issue 4, 2014, Pages 495-499

  Bilginer, Sinan ^a   Unluer, Elif ^a   Gul, Halise Inci ^a   Mete, Ebru ^a   Isik, Semra ^b   Vullo, Daniela ^b   Ozensoy Guler, Ozen ^b,c   Beyaztas, Serap ^b   Capasso, Clemente ^d   Supuran, Claudiu T ^b  

^a ATATÜRK UNIVERSITY   (Turkey)

^b UNIVERSITY OF FLORENCE   (Italy)

^c YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^d INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

Author keywords

Antifungalscarbonic anhydrase; Phenols; Pyridylethenyl carbonyl; Saccharomyces cerevisiae

Indexed keywords

2 PYRIDYL ETHENYLCARBONYL; 3 PYRIDYL ETHENYLCARBONYL; ACETAZOLAMIDE; ANTIFUNGAL AGENT; BETA CARBONIC ANHYDRASE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; PHENOL DERIVATIVE; PYRROLE DERIVATIVE; SULFONAMIDE; TERTIARY AMINE; UNCLASSIFIED DRUG; AMINE; ISOENZYME; PYRIDINE DERIVATIVE;

AMINO ACID SEQUENCE; ANTIFUNGAL RESISTANCE; ARTICLE; CRYSTAL STRUCTURE; ENZYME INHIBITION; NONHUMAN; PHYLOGENETIC TREE; PHYLOGENY; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; ENZYMOLOGY; HUMAN; METABOLISM; MOLECULAR GENETICS; SEQUENCE ALIGNMENT; SYNTHESIS;

AMINES; AMINO ACID SEQUENCE; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PHENOLS; PHYLOGENY; PYRIDINES; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84904300213     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2013.806497     Document Type: Article

References (34)

1. Elleuche S, Pöggeler S. Carbonic anhydrases in fungi. Microbiology 2010;156:23-9.
2. Klengel T, Liang WJ, Chaloupka J, et al. Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence. Curr Biol 2005;15:2021-6.
3. Hall RA, Mühlschlegel FA. Fungal and nematode carbonic anhydrases: Their inhibition in drug design. In: Supuran CT, Winum JY, eds. Drug design of zinc-enzyme inhibitors: Functional, structural, and disease applications. Hoboken: John Wiley & Sons; 2009:301-22.
4. Ohndorf UM, Schlicker C, Steegborn C. Crystallographic studies on carbonic anhydrases from fungal pathogens for structure-Assisted drug development. In: Supuran CT, Winum JY, eds. Drug design of zinc-enzyme inhibitors: Functional, structural, and disease applications. Hoboken: John Wiley & Sons; 2009:323-34.
5. Innocenti A, Leewattanapasuk W, Mühlschlegel FA, et al. Carbonic anhydrase inhibitors. Inhibition of the b-class enzyme from the pathogenic yeast Candida glabrata with anions. Bioorg Med Chem Lett 2009;19:4802-5.
6. Schlicker C, Hall RA, Vullo D, et al. Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans. J Mol Biol 2009;385:1207-20.
7. De Simone G, Supuran CT. (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 2012;111:117-29.
8. Cottier F, Leewattanapasuk W, Kemp LR, et al. Carbonic anhydrase regulation and CO2 sensing in the fungal pathogen Candida glabrata involves a novel Rca1p ortholog. Bioorg Med Chem 2013;21: 1549-54.
9. Carta F, Innocenti A, Hall RA, et al. Carbonic anhydrase inhibitors. Inhibition of the b-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic-/aromatic carboxylates and their derivatives. Bioorg Med Chem Lett 2011;21:2521-6.
10. Innocenti A, Mühlschlegel FA, Hall RA, et al. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with simple anions. Bioorg Med Chem Lett 2008;18:5066-70.
11. Isik S, Kockar F, Aydin M, et al. Carbonic anhydrase inhibitors. Inhibition of the b-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates. Bioorg Med Chem 2009;17:1158-63.
12. Isik S, Kockar F, Arslan O, et al. Carbonic anhydrase inhibitors. Inhibition of the b-class enzyme from the yeast Saccharomyces cerevisiae with anions. Bioorg Med Chem Lett 2008;18:6327-31.
13. Isik S, Kockar F, Aydin M, et al. Carbonic anhydrase activators: Activation of the b-carbonic anhydrase Nce103 from the yeast Saccharomyces cerevisiae with amines and amino acids. Bioorg Med Chem Lett 2009;19:1662-5.
14. Hewitson KS, Vullo D, Scozzafava A, et al. Molecular cloning, characterization and inhibition studies of a b-carbonic anhydrase from Malassezia globosa, a potential antidandruff target. J Med Chem 2012;55:3513-20.
15. Alterio V, Di Fiore A, D'Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoformŞ. Chem Rev 2012;112:4421-68.
16. Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81.
17. Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759-72.
18. Supuran CT. Carbonic anhydrases: From biomedical applications of the inhibitors and activators to biotechnologic use for CO2 capture. J. Enzyme Inhib Med Chem 2013;28:229-30.
19. Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467-74.
20. Singh S, Supuran CT. QSARs on human carbonic anhydrase VA and VB inhibitors of some new not yet synthesized, substituted aromatic/heterocyclic sulphonamides as anti-obesity agent. J Enzyme Inhib Med Chem 2012;27:666-72.
21. Ekinci D, Kurbanoglu NI, Salamç E, et al. Carbonic anhydrase inhibitors: Inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds. J Enzyme Inhib Med Chem 2012;27:845-8.
22. Bootorabi F, Jänis J, Hytönen VP, et al. Acetaldehyde-derived modifications on cytosolic human carbonic anhydrases. J Enzyme Inhib Med Chem 2011;26:862-70.
23. Supuran CT. Bacterial carbonic anhydrases as drug targets: Toward novel antibioticŞ. Front Pharmacol 2011;2:1-6.
24. Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146-89.
25. Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nature Rev Drug Discov 2011;10:767-77.
26. Liu F, Martin-Mingot A, Lecornué F, et al. Carbonic anhydrases inhibitory effects of new benzenesulfonamides synthesized by using superacid chemistry. J Enzyme Inhib Med Chem 2012;27:886-91.
27. Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I - XIV). Bioorg Med Chem Lett 2008;18:1583-7.
28. Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem 2008;16:7424-8.
29. Sahin H, Aliyazicioglu R, Yildiz O, et al. Honey, pollen, and propolis extracts show potent inhibitory activity against the zinc metalloenzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2011;26:440-4.
30. Bilginer S, Gul HI, Mete E, et al. 1-(3-Aminomethyl-4-hydroxyphenyl)- 3-pyridinyl-2-propen-1-ones: A novel group of tumourelective cytotoxins. J Enzyme Inhib Med Chem 2013;28:1-7.
31. Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561-73.
32. Kolayli S, Karahalil F, Sahin H, et al. Characterization and inhibition studies of an a-carbonic anhydrase from the endangered sturgeon species Acipenser gueldenstaedti. J Enzyme Inhib Med Chem 2011;26:895-900.
33. Ozensoy O, Arslan M, Supuran CT. Carbonic anhydrase inhibitors: Purification and inhibition studies of pigeon (Columba livia var. domestica) red blood cell carbonic anhydrase with sulfonamides. J Enzyme Inhib Med Chem 2011;26:749-53.
34. Alafeefy AM, Isik S, Al-Jaber NA, et al. Carbonic anhydrase inhibitors. Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae b-carbonic anhydrase. Bioorg Med Chem Lett 2013;23:3570-5.